|
|
Expressions and clinical significance of PTEN and survivin in retinoblastoma tissues |
HUANG Haidong,LI Liyang,GUO Ying,ZHAO Xing,KANG Jingjia,and GUAN Di |
Department of Ophthalmology, Liaoning Provinial Corps Hospital, Chinese People’s Armed Police Forces. Shenyang 110034, China |
|
|
Abstract Objective To study the expressions and clinical significance of PTEN and survivin in retinoblastoma tissues. Methods Retinoblastoma tissue sections from 30 patients were selected as observation group, 30 healthy retinal tissue sections were selected as control group. Immunohistochemical method was used to detect the PTEN and survivin expressions, Expressions of PTEN and survivin were compared between the two groups, and their clinical significance was discussed. Results In the observation group, PTEN-positive expression rate was 53.3%;in the control group, the total positive expression rate of PTEN was 100%. In the observation group, the total positive expression rate of survivin was 60%;in the control group, the total positive expression rate of survivin was 0%;the difference between the two groups was significant(P<0.05). Conclusions In retinoblastoma tissues, the survivin-positive expression was significantly increased and PTEN-positive expression was significantly reduced.
|
Received: 27 February 2013
|
|
|
|
|
[5] |
苗丽霞, 李 明, 王亚峰, 等.CIK细胞联合化疗治疗儿童中晚期视网膜母细胞瘤的安全性及初步疗效观察[J].武警医学, 2012, 23(11):135-137.
|
[6] |
赵水喜, 曹京旭, 王迎选.视网膜母细胞瘤的外照射放疗[J].武警医学, 2012, 23(10):768-769.
|
[1] |
吴子旭, 郭晓铭, 姚 宏, 等.PTEN和Survivin在视网膜母细胞瘤中的表达和意义[J].中国药物与临床, 2010, 10(6):1645-1647.
|
[2] |
李 雁, 张军军.视网膜母细胞瘤发病机制的分子生物学研究回顾与进展[J].国际眼科杂志, 2010, 10(4):703-705.
|
[3] |
Dimaras H, Dimba E A, Gallic B L.Challenging the global retinoblastoma survival disparity through a collaborative research effort[J].Br J Ophthalmol, 2010, 94(11):1415-1416.
|
[4] |
乔丽珊, 方 严.视网膜母细胞瘤的临床特点和治疗分析[J].临床眼科杂志, 2007, 15(3):239-241.
|
[5] |
苗丽霞, 李 明, 王亚峰, 等.CIK细胞联合化疗治疗儿童中晚期视网膜母细胞瘤的安全性及初步疗效观察[J].武警医学, 2012, 23(11):135-137.
|
[6] |
赵水喜, 曹京旭, 王迎选.视网膜母细胞瘤的外照射放疗[J].武警医学, 2012, 23(10):768-769.
|
|
|
|